Telsey Advisory Group reiterated their outperform rating on shares of Vital Farms (NASDAQ:VITL - Free Report) in a research report released on Friday,Benzinga reports. Telsey Advisory Group currently has a $52.00 price objective on the stock. Telsey Advisory Group also issued estimates for Vital Farms' Q1 2025 earnings at $0.27 EPS, Q2 2025 earnings at $0.28 EPS, Q3 2025 earnings at $0.26 EPS, FY2025 earnings at $1.25 EPS, FY2026 earnings at $1.50 EPS and FY2027 earnings at $1.90 EPS.
VITL has been the topic of a number of other research reports. Stifel Nicolaus raised Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 target price on the stock in a report on Friday. TD Cowen upped their price target on shares of Vital Farms from $41.00 to $45.00 and gave the company a "buy" rating in a research report on Wednesday, January 8th. Craig Hallum initiated coverage on shares of Vital Farms in a report on Friday, December 20th. They issued a "buy" rating and a $50.00 price objective on the stock. Finally, Jefferies Financial Group reduced their target price on shares of Vital Farms from $45.00 to $41.00 and set a "buy" rating for the company in a report on Monday, November 11th. Eight analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average price target of $44.57.
Read Our Latest Research Report on Vital Farms
Vital Farms Stock Down 1.3 %
NASDAQ VITL traded down $0.40 during mid-day trading on Friday, reaching $31.15. The stock had a trading volume of 1,248,798 shares, compared to its average volume of 959,316. The stock has a market cap of $1.36 billion, a PE ratio of 27.81 and a beta of 0.90. Vital Farms has a 1 year low of $18.12 and a 1 year high of $48.41. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.24 and a quick ratio of 2.81. The company has a fifty day moving average price of $38.55 and a 200 day moving average price of $35.72.
Vital Farms (NASDAQ:VITL - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $0.23 earnings per share for the quarter, topping analysts' consensus estimates of $0.15 by $0.08. The business had revenue of $165.99 million during the quarter, compared to analyst estimates of $160.32 million. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. On average, research analysts expect that Vital Farms will post 1.11 earnings per share for the current year.
Insider Activity at Vital Farms
In related news, CEO Russell Diez-Canseco sold 44,728 shares of the firm's stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $37.66, for a total transaction of $1,684,456.48. Following the completion of the sale, the chief executive officer now directly owns 613,797 shares of the company's stock, valued at approximately $23,115,595.02. This trade represents a 6.79 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Matthew Ohayer sold 24,000 shares of the stock in a transaction on Thursday, December 19th. The stock was sold at an average price of $38.19, for a total value of $916,560.00. Following the completion of the sale, the insider now owns 7,038,890 shares in the company, valued at approximately $268,815,209.10. The trade was a 0.34 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 190,202 shares of company stock worth $7,855,957. Insiders own 27.60% of the company's stock.
Hedge Funds Weigh In On Vital Farms
A number of hedge funds have recently added to or reduced their stakes in VITL. Wellington Management Group LLP boosted its holdings in shares of Vital Farms by 417.8% in the fourth quarter. Wellington Management Group LLP now owns 2,431,024 shares of the company's stock valued at $91,625,000 after purchasing an additional 1,961,550 shares during the period. Principal Financial Group Inc. boosted its position in Vital Farms by 78.7% during the fourth quarter. Principal Financial Group Inc. now owns 1,171,950 shares of the company's stock valued at $44,172,000 after purchasing an additional 516,139 shares in the last quarter. Lord Abbett & CO. LLC boosted its position in Vital Farms by 64.6% during the fourth quarter. Lord Abbett & CO. LLC now owns 1,058,753 shares of the company's stock valued at $39,904,000 after purchasing an additional 415,614 shares in the last quarter. Emerald Advisers LLC grew its stake in Vital Farms by 106.8% in the third quarter. Emerald Advisers LLC now owns 706,440 shares of the company's stock valued at $24,775,000 after purchasing an additional 364,837 shares during the last quarter. Finally, Jupiter Asset Management Ltd. raised its holdings in Vital Farms by 96.3% in the fourth quarter. Jupiter Asset Management Ltd. now owns 628,709 shares of the company's stock worth $23,696,000 after purchasing an additional 308,425 shares in the last quarter. 98.59% of the stock is currently owned by institutional investors.
Vital Farms Company Profile
(
Get Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Recommended Stories

Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.